Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities    
Net loss $ (1,178) $ (927)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation expense 1,958 1,890
Amortization expense 810 924
Amortization of debt issuance costs 40 40
Unrealized loss on equity securities 852 53
Deferred income taxes 1,319 (56)
Gain on sale of equity securities 0 (326)
Earn-out adjustments 4 17
Payments on earn-out liabilities in excess of acquisition date fair value (292) (370)
Provision for losses on accounts receivable 141 134
Provision for losses on inventories 358 418
Non-cash lease expense 128 137
Non-cash lease termination loss 11 0
Change in fair value of interest rate swap 85 48
Stock-based compensation expense 336 615
Changes in operating assets and liabilities:    
Accounts receivable (7,737) (2,393)
Inventories 676 5,190
Other assets and liabilities 2 631
Accounts payable 5,668 3,966
Accrued expenses (1,085) (3,541)
Accrued income taxes (2,738) (351)
Net cash (used in) provided by operating activities (642) 6,099
Investing activities    
Purchases of property, plant and equipment (587) (964)
Proceeds from sale of equity securities 0 850
Purchase of equity securities 0 (544)
Acquisition of ASTI 0 (21,895)
Net cash used in investing activities (587) (22,553)
Financing activities    
Borrowings (repayments) from line of credit 3,201 (4,258)
Borrowings from term loan 0 20,000
Payments on long-term debt (1,000) (666)
Principal payments on finance lease obligations (64) (47)
Payments for finance lease terminations (14) 0
Payments on earn-out liabilities (863) (190)
Repurchase of common stock (635) 0
Net cash provided by financing activities 625 14,839
Decrease in cash and cash equivalents (604) (1,615)
Cash and cash equivalents at beginning of period 626 2,220
Cash and cash equivalents at end of period 22 605
Supplemental disclosure    
Interest $ 667 $ 878